ID   HeLa NR1
AC   CVCL_1277
SY   HeLaNR1
DR   CLO; CLO_0003693
DR   ATCC; CRL-13011
DR   Wikidata; Q54882549
RX   Patent=US6326196;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12510.
CC   Population: African American.
CC   Transfected with: UniProtKB; P27967; Barley nitrate reductase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CRL-13011
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related cervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
RX   Patent=US6326196;
RA   Parker J.E., Kiel J.L.;
RT   "Nitrate reductase-transfected HeLa cells for cancer and microwave
RT   bioeffects research.";
RL   Patent number US6326196, 04-Dec-2001.
//